全文获取类型
收费全文 | 16543篇 |
免费 | 1687篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 144篇 |
儿科学 | 538篇 |
妇产科学 | 522篇 |
基础医学 | 2405篇 |
口腔科学 | 270篇 |
临床医学 | 1954篇 |
内科学 | 3202篇 |
皮肤病学 | 189篇 |
神经病学 | 1289篇 |
特种医学 | 668篇 |
外国民族医学 | 3篇 |
外科学 | 1999篇 |
综合类 | 366篇 |
一般理论 | 11篇 |
预防医学 | 1897篇 |
眼科学 | 368篇 |
药学 | 1299篇 |
中国医学 | 12篇 |
肿瘤学 | 1123篇 |
出版年
2021年 | 206篇 |
2020年 | 143篇 |
2019年 | 236篇 |
2018年 | 256篇 |
2017年 | 206篇 |
2016年 | 233篇 |
2015年 | 237篇 |
2014年 | 336篇 |
2013年 | 515篇 |
2012年 | 690篇 |
2011年 | 771篇 |
2010年 | 463篇 |
2009年 | 390篇 |
2008年 | 658篇 |
2007年 | 698篇 |
2006年 | 628篇 |
2005年 | 663篇 |
2004年 | 659篇 |
2003年 | 652篇 |
2002年 | 567篇 |
2001年 | 540篇 |
2000年 | 548篇 |
1999年 | 455篇 |
1998年 | 210篇 |
1997年 | 180篇 |
1996年 | 164篇 |
1995年 | 182篇 |
1994年 | 159篇 |
1993年 | 157篇 |
1992年 | 404篇 |
1991年 | 401篇 |
1990年 | 411篇 |
1989年 | 357篇 |
1988年 | 385篇 |
1987年 | 373篇 |
1986年 | 334篇 |
1985年 | 314篇 |
1984年 | 265篇 |
1983年 | 227篇 |
1982年 | 133篇 |
1979年 | 217篇 |
1978年 | 173篇 |
1977年 | 146篇 |
1976年 | 155篇 |
1975年 | 153篇 |
1974年 | 153篇 |
1973年 | 175篇 |
1972年 | 142篇 |
1971年 | 129篇 |
1970年 | 137篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
The incidence of transient hypogammaglobulinaemia of infancy (THI) detected in a major paediatric centre over a 10 year period was examined. A total of 2468 subjects less than 2 years of age had an IgG measurement taken between July 1979 and March 1990. Subjects with known immunodeficiencies were excluded. Fifteen patients were classified as having THI with an initial IgG level less than the fifth centile followed by a second measurement within the normal range. A further 24 patients were identified as having possible THI with a single low IgG concentration. There were 60,174 live births each year in Victoria in the years 1979-88. This gives an incidence of proved THI of 23 per 10(6) births, and including proved and probable THI an incidence of 61 per 10(6) live births. Of those patients with proved THI 12/15 had symptoms of either atopic disease or food allergy/intolerance and three had gastrointestinal symptoms without any evidence of atopic disease. At presentation 12/15 (80%) were IgA deficient and 9/15 had IgM concentrations less than the 20th centile for age. It is suggested that in view of the preponderance of atopic and food intolerant patients that subclinical protein loss from the bowel due to allergic inflammation may be a contributing factor to the development of THI in some patients. 相似文献
35.
36.
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. 总被引:2,自引:0,他引:2
C Anasetti P J Martin R Storb F R Appelbaum P G Beatty J Davis K Doney H F Hill P Stewart K M Sullivan 《Transplantation》1992,54(5):844-851
Treatment with the monoclonal antibody OKT3 specific for the CD3 complex associated with the T cell antigen receptor can reverse acute rejection of human renal allografts. However, efficacy of anti-CD3 antibodies for treatment of patients with acute graft-versus-host disease after marrow transplantation has not been established. The dose-limiting side effects resulting from T cell activation induced by some anti-CD3 antibodies in vivo have discouraged their use for this application. We now report a phase I-II study of GVHD treatment with the anti-CD3 antibody BC3, a monoclonal murine IgG2b that, unlike OKT3, does not activate T cells. Fourteen patients were treated with BC3 after progression of acute GVHD despite treatment with cyclosporine and corticosteroids, and three patients received BC3 as primary treatment for GVHD. BC3 was administered at a dose of 0.1 or 0.2 mg/kg/day for seven or eight days. Five patients achieved complete resolution of GVHD, eight patients had partial improvement, two patients had no change, and two patients had progression of GVHD on therapy. Responses were sustained in 8 of 13 patients. Mild chills, fever, hypertension, and chest discomfort occurred in various combinations following 6 of 17 (35%) initial infusions of BC3 and following 4 of 99 (4%) subsequent infusions. In each instance it was possible to continue BC3 therapy without adjusting the dose or treatment schedule. In each patient treated, the absolute count of peripheral blood lymphocytes decreased transiently but returned to baseline within 22 hr after the first infusion. Circulating T cells had surface CD3 molecules saturated by the infused antibody in all but one patient. Four patients survived longer than one year after treatment with antibody BC3, and 13 patients died of infection or organ failure. Administration of the nonmitogenic anti-CD3 antibody BC3 was associated with improvement in the clinical manifestations of GVHD with minimal acute toxicity. Efficacy of antibody treatment did not depend on depletion of circulating T cells. Therefore, antibody BC3 may be achieving therapeutic immunosuppression by modulating T cell function. Controlled studies in patients treated earlier in the course of GVHD should determine whether antibody BC3 can improve survival. 相似文献
37.
N D Kock E P Lane F Rowbotham A Pawandiwa F W Hill 《Journal of comparative pathology》1991,104(1):117-120
A young dog with progressive neurological signs was humanely killed by the injection of barbiturate for postmortem examination. Lesions in the nose, lung, pancreas, lymph nodes, kidneys and the meninges were heavily infiltrated with Cryptococcus neoformans. In addition, haemangiosarcoma was detected in the right atrium. The finding of systemic mycosis and neoplasia together in a young dog suggests an immunosuppressed state. 相似文献
38.
Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy 总被引:2,自引:0,他引:2
N C Hill M Selinger J Ferguson I Z MacKenzie 《Human reproduction (Oxford, England)》1991,6(3):458-462
The maternal and fetal endocrine effects of the maternal administration of the anti-progestin mifepristone in mid-pregnancy have been investigated. Mifepristone and the metabolite RU 42,633 were detected in the fetal circulation and in the amniotic fluid 4, 24 and 48 h after oral ingestion. Maximum fetal plasma concentrations of mifepristone occurred 4 h after treatment indicating rapid placental transfer of the drug. No significant changes in progesterone, cortisol, oestradiol or aldosterone concentrations were detected in the maternal circulation after mifepristone treatment. No significant changes occurred in the fetal progesterone, oestradiol or cortisol concentrations, but a significant increase in fetal aldosterone occurred 4 and 24 h after treatment. The significance of these results is discussed in relation to the possible therapeutic uses of mifepristone for inducing labour. 相似文献
39.
This study examined the use of autologous fat as an alternative to Teflon® and collagen as the implantable material in vocal cord medialization. Five animals underwent left recurrent laryngeal nerve sections with subsequent fat harvest and implantation into the left true vocal cords. Three animals were killed after 48 hours and 2 after 3 weeks; their larynges were examined with light microscopy. The results of the 48-hour samples show moderate acute inflammation and few areas of focal necrosis. The 3-week samples show no necrotic foci, minimal foreign-body reaction, and maintenance of structure and volume of the injected fat. Autologous fat may prove to be a valuable alternative to nonautologous injectable material in vocal cord augmentation. 相似文献
40.